Effects of acronycine on cell-surface properties of murine leukemia cells.
D000175:Acronine / Q000494:pharmacology* / Q000627:therapeutic use; D000470:Alkaloids / Q000494:pharmacology*; D000596:Amino Acids / Q000378:metabolism; D000817:Anilino Naphthalenesulfonates; D000818:Animals; D002103:Cadaverine; D002462:Cell Membrane / Q000378:metabolism; D002478:Cells, Cultured; D003619:Dansyl Compounds; D004586:Electrophoresis; D005453:Fluorescence; D007939:Leukemia L1210 / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D007942:Leukemia, Experimental / Q000378:metabolism / Q000473:pathology*; D051379:Mice; D009363:Neoplasm Proteins / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism; D014529:Uridine / Q000378:metabolism
D000470:Alkaloids; D000596:Amino Acids; D000817:Anilino Naphthalenesulfonates; D003619:Dansyl Compounds; D009363:Neoplasm Proteins; D002103:Cadaverine; D000175:Acronine; D013936:Thymidine; D014529:Uridine